Effects of oxidized low‐ and high‐density lipoproteins on gene expression of human macrophages

References

• Stary H. C., Chandler A. B., Glagov S., Guyton J. R., Insull W., Jr., Rosenfeld M. E., et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994; 89: 2462–78
   PubMed Web of Science ®Google Scholar
• Kruth H. S. Macrophage foam cells and atherosclerosis. Front Biosci 2001; 6: D429–55
   PubMed Web of Science ®Google Scholar
• Goldstein J. L., Ho Y. K., Basu S. K., Brown M. S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979; 76: 333–7
   PubMed Web of Science ®Google Scholar
• Zha X., Tabas I., Leopold P. L., Jones N. L., Maxfield F. R. Evidence for prolonged cell‐surface contact of acetyl‐LDL before entry into macrophages. Arterioscler Thromb Vasc Biol 1997; 17: 1421–31
   Google Scholar
• Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115–26
   PubMed Web of Science ®Google Scholar
• Lusis A. J. Atherosclerosis. Nature 2000; 407: 233–41
   PubMed Web of Science ®Google Scholar
• Camejo G., Hurt‐Camejo E., Wiklund O., Bondjers G. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis 1998; 139: 205–22
   PubMed Web of Science ®Google Scholar
• Heinecke J. W. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 1998; 141: 1–15
   PubMed Web of Science ®Google Scholar
• Frei B., Stocker R., Ames B. N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988; 85: 9748–52
   PubMed Web of Science ®Google Scholar
• Ylä‐Herttuala S., Lipton B. A., Rosenfeld M. E., Särkioja T., Yoshimura T., Leonard E. J., et al. Expression of monocyte chemoattractant protein 1 in macrophage‐rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991; 88: 5252–6
   PubMed Web of Science ®Google Scholar
• Rajavashisth T. B., Andalibi A., Territo M. C., Berliner J. A., Navab M., Fogelman A. M., et al. Induction of endothelial cell expression of granulocyte and macrophage colony‐stimulating factors by modified low‐density lipoproteins. Nature 1990; 344: 254–7
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–9
   PubMed Web of Science ®Google Scholar
• Francis G. A. High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences. Biochim Biophys Acta 2000; 1483: 217–35
   PubMed Web of Science ®Google Scholar
• Fielding C. J., Fielding P. E. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995; 36: 211–28
   PubMed Web of Science ®Google Scholar
• Salonen J. T., Malin R., Tuomainen T. P., Nyyssönen K., Lakka T. A., Lehtimäki T. Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case‐control study. Br Med J 1999; 319: 487–9; discussion 90
   PubMed Web of Science ®Google Scholar
• Malin R., Rantalaiho V., Huang X. H., Wirta O., Pasternack A., Leinonen J. S., et al. Association between M/L55‐polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects. Hum Genet 1999; 105: 179–80
   PubMedGoogle Scholar
• Maier J. A., Barenghi L., Pagani F., Bradamante S., Comi P., Ragnotti G. The protective role of high‐density lipoprotein on oxidized‐low‐density‐lipoprotein‐induced U937/endothelial cell interactions. Eur J Biochem 1994; 221: 35–41
   Google Scholar
• Nishigaki I., Hagihara M., Tsunekawa H., Maseki M., Yagi K. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med 1981; 25: 373–8
   PubMed Web of Science ®Google Scholar
• Nagano Y., Arai H., Kita T. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci USA 1991; 88: 6457–61
   PubMed Web of Science ®Google Scholar
• Hurtado I., Fiol C., Gracia V., Caldu P. In vitro oxidised HDL exerts a cytotoxic effect on macrophages. Atherosclerosis 1996; 125: 39–46
   Google Scholar
• Greilberger J., Jurgens G. Oxidation of high‐density lipoprotein HDL3 leads to exposure of apo‐AI and apo‐AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low‐density lipoprotein to type I and type III collagen in vitro 1. Biochem J 1998; 331: 185–91
   PubMedGoogle Scholar
• Mikita T., Porter G., Lawn R. M., Shiffman D. Oxidized low density lipoprotein exposure alters the transcriptional response of macrophages to inflammatory stimulus. J Biol Chem 2001; 276: 45729–39
   PubMed Web of Science ®Google Scholar
• Llaverias G., Noe V., Penuelas S., Vazquez‐Carrera M., Sanchez R. M., Laguna J. C., et al. Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL‐treated human macrophages. Biochem Biophys Res Commun 2004; 318: 265–74
   PubMedGoogle Scholar
• Jaakkola O., Ylä‐Herttuala S., Särkioja T., Nikkari T. Macrophage foam cells from human aortic fatty streaks take up beta‐VLDL and acetylated LDL in primary culture. Atherosclerosis 1989; 79: 173–82
   Google Scholar
• Lehtimäki T., Lehtinen S., Solakivi T., Nikkilä M., Jaakkola O., Jokela H., et al. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. Arterioscler Thromb Vasc Biol 1999; 19: 23–7
   PubMed Web of Science ®Google Scholar
• Shiffman D., Mikita T., Tai J. T., Wade D. P., Porter J. G., Seilhamer J. J., et al. Large scale gene expression analysis of cholesterol‐loaded macrophages. J Biol Chem 2000; 275: 37324–32
   PubMed Web of Science ®Google Scholar
• Hiltunen M. O., Tuomisto T. T., Niemi M., Brasen J. H., Rissanen T. T., Toronen P., et al. Changes in gene expression in atherosclerotic plaques analyzed using DNA array. Atherosclerosis 2002; 165: 23–32
   Google Scholar
• Armstrong P. J., Johanning J. M., Calton W. C Jr., Delatore J. R., Franklin D. P., Han D. C., et al. Differential gene expression in human abdominal aorta: aneurysmal versus occlusive disease. J Vasc Surg 2002; 35: 346–55
   PubMed Web of Science ®Google Scholar
• Niu X., Zammit V., Upston J. M., Dean R. T., Stocker R. Coexistence of oxidized lipids and alpha‐tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 1999; 19: 1708–18
   PubMed Web of Science ®Google Scholar
• Nakajima T., Origuchi N., Matsunaga T., Kawai S., Hokari S., Nakamura H., et al. Localization of oxidized HDL in atheromatous plaques and oxidized HDL binding sites on human aortic endothelial cells. Ann Clin Biochem 2000; 37: 179–86
   Google Scholar
• Stocker R. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance. Curr Opin Lipidol 1994; 5: 422–33
   PubMedGoogle Scholar
• Coe N. R., Bernlohr D. A. Physiological properties and functions of intracellular fatty acid‐binding proteins. Biochim Biophys Acta 1998; 1391: 287–306
   PubMed Web of Science ®Google Scholar
• Willnow T. E., Armstrong S. A., Hammer R. E., Herz J. Functional expression of low density lipoprotein receptor‐related protein is controlled by receptor‐associated protein in vivo. Proc Natl Acad Sci USA 1995; 92: 4537–41
   PubMed Web of Science ®Google Scholar
• Willnow T. E. Receptor‐associated protein (RAP): a specialized chaperone for endocytic receptors. Biol Chem 1998; 379: 1025–31
   PubMedGoogle Scholar
• Aoyama T., Uchida Y., Kelley R. I., Marble M., Hofman K., Tonsgard J. H., et al. A novel disease with deficiency of mitochondrial very‐long‐chain acyl‐CoA dehydrogenase. Biochem Biophys Res Commun 1993; 191: 1369–72
   PubMed Web of Science ®Google Scholar
• Miller M. D., Wilson S. D., Dorf M. E., Seuanez H. N., O'Brien S. J., Krangel M. S. Sequence and chromosomal location of the I‐309 gene. Relationship to genes encoding a family of inflammatory cytokines. J Immunol 1990; 145: 2737–44
   Google Scholar
• Haque N. S., Zhang X., French D. L., Li J., Poon M., Fallon J. T., et al. CC chemokine I‐309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells. Circulation 2000; 102: 786–92
   PubMed Web of Science ®Google Scholar
• Bernardini G., Spinetti G., Ribatti D., Camarda G., Morbidelli L., Ziche M., et al. I‐309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. Blood 2000; 96: 4039–45
   PubMed Web of Science ®Google Scholar
• Leung D. W., Cachianes G., Kuang W. J., Goeddel D. V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306–9
   PubMed Web of Science ®Google Scholar
• Dvorak H. F., Brown L. F., Detmar M., Dvorak A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029–39
   PubMed Web of Science ®Google Scholar
• Meade T. W., Mellows S., Brozovic M., Miller G. J., Chakrabarti R. R., North W. R., et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533–7
   PubMed Web of Science ®Google Scholar
• Wilhelmsen L., Svardsudd K., Korsan‐Bengtsen K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501–5
   PubMed Web of Science ®Google Scholar
• Salonen J. T., Seppänen K., Rauramaa R., Salonen R. Risk factors for carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Med 1989; 21: 227–9
   Web of Science ®Google Scholar
• Belloc F., Hourdille P., Fialon P., Boisseau M. R., Soria J. Fibrinogen synthesis by megakaryocyte‐rich human marrow cell concentrates. Thromb Res 1985; 38: 341–51
   Google Scholar
• Uzan G., Courtois G., Stanckovic Z., Crabtree G. R., Marguerie G. Expression of the fibrinogen genes in rat megakaryocytes. Biochem Biophys Res Commun 1986; 140: 543–9
   PubMedGoogle Scholar
• Haidaris P. J. Induction of fibrinogen biosynthesis and secretion from cultured pulmonary epithelial cells. Blood 1997; 89: 873–82
   PubMed Web of Science ®Google Scholar
• Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 1995; 130: 503–6
   PubMed Web of Science ®Google Scholar
• Hamsten A., Eriksson P. Thrombospondins and premature coronary artery disease: time to go beyond genotype‐phenotype association studies. Arterioscler Thromb Vasc Biol 2003; 23: 6–7
   Google Scholar